Latanoprostene Bunod Ophthalmic Solution, 0.024% Solution/ Drops
Product Images NDC 68083-563

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Latanoprostene Bunod Ophthalmic Solution, 0.024% (NDC 68083-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label-2-5ml (Bottle Label 2 5ml)

Label of Latanoprostene Bunod Ophthalmic Solution 0.024%, a sterile prescription eye drop solution in a 2.5 mL container. The label includes the NDC 68083-563-01, manufacturer Gland Pharma Limited, Hyderabad, India, and indicates the product is for eye use only. It also displays barcode and spaces for lot and expiration dates.*

FDA Label Image

Bottle-label-5ml (Bottle Label 5ml)

Label of Latanoprostene Bunod Ophthalmic Solution 0.024% in 5 mL solution/drops. The label includes storage instructions to refrigerate unopened bottles at 2° to 8°C and after opening to store at 2° to 25°C for up to 8 weeks, warnings to protect from light and freezing, and indicates the product is sterile, prescription only, and for eye use. Manufactured by Gland Pharma Limited in Hyderabad, India.*

FDA Label Image

Carton-label-2-5ml (Carton Label 2 5ml)

Label for Latanoprostene Bunod Ophthalmic Solution 0.024%, a 2.5 mL sterile prescription eye drop solution by Gland Pharma Limited. The label displays the NDC 68083-563-01, active ingredient concentration, usage instructions for eye use only, storage requirements, and manufacturer details. The design includes a grayscale eye graphic and barcode.*

FDA Label Image

Carton-label-5ml (Carton Label 5ml)

Packaging label for Latanoprostene Bunod Ophthalmic Solution, 0.024%, 5 mL sterile eye drops by Gland Pharma Limited. The label includes the active ingredient concentration, storage instructions to refrigerate unopened bottles at 2 to 8°C, and usage notes indicating it is for eye use only and prescription use. Additional details list inactive ingredients and preservative benzalkonium chloride.*

FDA Label Image

Latanoprostene-bunod-spl-structure (Latanoprostene Bunod Spl Structure)

Chemical structure of Latanoprostene Bunod, an ophthalmic solution at 0.024% concentration. The diagram shows the molecular structure with various chemical bonds and functional groups characteristic of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.